New York – ConvergEx Group, a provider of investment technologies and execution solutions to institutional clients, announced yesterday that it has entered into an alliance with the Marwood Group, a healthcare advisory and financial services firm based in New York. Through the agreement, clients will be able to use ConvergEx’s execution technologies to generate credits for Marwood’s healthcare research.
Edward Kennedy Jr., President and co-founder of the Marwood Group, said: “We are very pleased to introduce our clients to ConvergEx so they will benefit from the access to Wall Street’s largest aggregator of soft-dollars as well as their advanced, global capabilities.”
ConvergEx Group is a leading financial technology company that provides investment technologies and execution solutions in global markets. Its 6,000 institutional clients include many of the prominent asset managers, hedge funds, corporations, plan sponsors, broker-dealers and financial intermediaries. Formed in 2006, the firm has over 1,000 employees in 22 locations throughout the U.S., Europe, Asia, Australia and Africa. Marwood, a New York City-based healthcare advisory firm with offices in Washington, DC and London, has over 95 employees and provides services to institutional investors, corporations, and trade associations.